Clinical Trials Directory

Trials / Unknown

UnknownNCT01339065

The Effect of Ketamine on Production of Inflammatory Markers in Post Operative Patients in Mulago Hospital

The Effect of Ketamine on Production of Inflammatory Markers in Post Operative Patients in Mulago Hospital: A Randomized Clinical Trial

Status
Unknown
Phase
Phase 4
Study type
Interventional
Enrollment
30 (estimated)
Sponsor
Makerere University · Academic / Other
Sex
All
Age
18 Years – 70 Years
Healthy volunteers
Accepted

Summary

. Null Hypothesis: Giving low doze ketamine (0.5mg/kg) given preoperatively to adult patients undergoing elective surgery, in Mulago hospital, will not have a reduction effect on the levels of IL-6 \& IL-1β pro inflammatory markers by 48 hours. . Alternate Hypothesis: Giving low doze ketamine (0.5mg/kg) given preoperatively to adult patients undergoing elective surgery, in Mulago hospital, will have a reduction effect on the levels of IL-6 \& IL-1β pro inflammatory markers by 48 hours.

Detailed description

RESEARCH QUESTION Can 0.5mg/kg of Ketamine given preoperatively have an effect on the levels of pro-inflammatory markers? Primary specific Outcome: changes/deviations from baseline levels of IL- 6 pro-inflammatory markers of after surgery at PACU, 24 and 48 hours. Secondary specific Outcome: changes/deviations from baseline levels of IL-1β pro-inflammatory markers of after surgery at PACU, 24 and 48 hours.

Conditions

Interventions

TypeNameDescription
DRUGKetaminedetermining the effect of low dose sub anesthetic doze of ketamine and placaebo on post operative patients

Timeline

Start date
2011-04-01
Primary completion
2011-05-01
Completion
2011-06-01
First posted
2011-04-20
Last updated
2011-04-20

Locations

1 site across 1 country: Uganda

Source: ClinicalTrials.gov record NCT01339065. Inclusion in this directory is not an endorsement.